Igg Protein Spike

Human-COVID-19-Spike-Protein-IgG-ELISA-Kit

E28AB0167 N/A
EUR 666.67
Description: N/A

Human IgG antibody Laboratories manufactures the igg protein spike reagents distributed by Genprice. The Igg Protein Spike reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike IgG. Other Igg products are available in stock. Specificity: Igg Category: Protein Group: Spike

Anti-Spike-RBD-fully-human-mAb(IgG)

Human,-Human-IgG1.Affinity:(mol)6.99*10-10(Fortebio),0.38-nM(ELISA).-FACs-Blocking:-0.803-nM-
EUR 416.5
Description: Human, Human IgG1.Affinity: (mol) 6.99*10-10 (Fortebio) , 0.38 nM (ELISA) . FACs Blocking: 0.803 nM

Anti-Spike-RBD-fully-human-mAb(IgG)

Human,-Human-IgG1.-Affinity:(mol)3.1*10-10(Fortebio)0.3-nM(ELISA).-FACs-Blocking:-0.889-nM.
EUR 416.5
Description: Human, Human IgG1. Affinity: (mol) 3.1*10-10 (Fortebio) 0.3 nM (ELISA) . FACs Blocking: 0.889 nM.

Anti-Spike-RBD-fully-human-mAb(IgG)

Humanized-Monoclonal-Antibody,-human-IgG1.-Affinity:0.561-nM(By-ELISA)
EUR 416.5
Description: Humanized Monoclonal Antibody, human IgG1. Affinity:0.561 nM (By ELISA)

Anti-Spike-RBD-fully-human-mAb(IgG)

Humanized-Monoclonal-Antibody.-human-IgG1.-Affinity:0.762-nM(By-ELISA)
EUR 416.5
Description: Humanized Monoclonal Antibody. human IgG1. Affinity:0.762 nM (By ELISA)

Anti-SARS-CoV-2 Antibody IgG Quantitative and Titer Detection Kit (Spike RBD)

96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection.

Anti-SARS-CoV-2 Antibody IgG Quantitative and Titer Detection Kit (Spike Trimer)

96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection.

Anti-SARS-CoV-2 Antibody IgG Quantitative and Titer Detection Kit (Spike S1)

96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection.

Spike information

Recombinant Spike Protein (SP)

RPX273Ge01 10ug
EUR 140

Recombinant Spike Protein (SP)

RPX273Ge03 10ug
EUR 140

Mouse Monoclonal Anti-SARS Spike IgG

AB-17910 50 ug
EUR 562.8

SARS Ag Spike Mosaic Protein

30-2003 1 mg Ask for price
Description: SARS Antigens Spike Mosaic Protein S (N)

SARS Ag Spike Mosaic Protein

30-2004 1 mg Ask for price
Description: SARS Antigens Spike Mosaic Protein S (C)

2019-nCoV Spike protein RBD

BSV-COV-PR-10 10 ug Ask for price
Description: 2019-nCoV Spike protein RBD (His-tag)

2019-nCoV Spike protein RBD

BSV-COV-PR-11 20 ug Ask for price
Description: 2019-nCoV Spike protein RBD (His-tag)

2019-nCoV Spike protein RBD

BSV-COV-PR-12 50 ug Ask for price
Description: 2019-nCoV Spike protein RBD (His-tag)

2019-nCoV Spike protein RBD

BSV-COV-PR-13 100 ug Ask for price
Description: 2019-nCoV Spike protein RBD (His-tag)

SARS-CoV2 FL Spike Protein

0573-001 100 ug
EUR 395

GENLISA Human Anti-SARS-CoV-2 (Covid-19) Spike Protein IgG ELISA - CE MARKED

KBVH015-2 1 x 96 wells
EUR 275

GENLISA™ Mouse SARS-CoV-2 IgG Antibody To Spike RBD Protein ELISA (Quantitative)

KBVH015-13 12 × 8 wells
EUR 2002.5

GENLISA™ Mouse SARS-CoV-2 IgG Antibody To Spike S1 Protein ELISA (Quantitative)

KBVH015-14 12 × 8 wells
EUR 2002.5

MERS Spike S1 Recombinant protein

39-102 0.1 mg
EUR 556.8
Description: Since April 2012, cases of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) have been identified in the following countries: Saudi Arabia, Qatar, Jordan, the United Arab Emirates, Oman, Kuwait, Yemen, Lebanon, Iran, Algeria, the United Kingdom, France, Italy, Greece, Germany, the Netherlands, Austria, Tunisia, Egypt, Malaysia, Turkey and the United States of America. Coronaviruses are the cause of the common cold, SARS (severe acute respiratory syndrome) and other severe illnesses with high mortality rates, all are classified into coronavirus family. MERS-CoV is a new type of SARS found in the coronavirus family causing severe pneumonia with sudden and serious respiratory illness with high mortality rates as well. Since January 27th 2015, the WHO has reported 956 human cases, including 351 deaths. More cases of the new coronavirus strain are expected. Like in other coronaviruses, large surface spike glycoprotein is a central structural protein of this virus; it is located above the virion surface to bind and enter into the target cell. Spike protein has 2 domains- S1 and S2. The S1 domain is responsible for cellular tropism and interaction with target cell, while the S2 domain is responsible for membrane fusion. The C-terminal of S1 domain contains a receptor binding domain, and is also a potential target for vaccine development and an antigen for diagnosis.

SARS-CoV spike protein Antibody

abx023139-100ug 100 ug
EUR 1028.4

SARS-CoV spike protein Antibody

abx023143-100ug 100 ug
EUR 1028.4

SARS Spike RBD Recombinant Protein

10-211 0.1 mg
EUR 651.3
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.